Newron Pharmaceuticals

Newron Pharmaceuticals is a company listed under the stock ticker NWPHF (IT).

View the org chart displaying its 11 main executives

Most searched biographies at Newron Pharmaceuticals

• Stefan Weber, Chief Executive Officer and Director
• Gillian Dines, Director
• Patrick Langlois, Director

Create your alert
to follow the executive moves at Newron Pharmaceuticals.

Newron Pharmaceuticals has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Lucia Aleotti - Director at Menarini Group

Learn more about the Pharmaceuticals industry >

Press releases by Newron Pharmaceuticals

• Newron announces AGM 2024 results
• Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)
• Invitation to attend the General Meeting
• Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)
• Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide
• Regulatory News 2024
• Newron announces H1 2023 results and provides R&D update
• Page not found
• Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
• Newron to present at the 34th CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
• View more press releases Close

Social media about Newron Pharmaceuticals

• Newron Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Newron Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Stefan Weber

Call Newron Pharmaceuticals at +39 ...

View the org chart

Register to receive your alert

Report an error